Hisamitsu Pharmaceutical Co., Inc.

HTSUF · OTC
Analyze with AI
2/28/2025
2/28/2024
2/28/2023
2/28/2022
Operating Activities
Net Income$29$14$16$13
Dep. & Amort.$6$5$5$4
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$6-$1-$0$4
Other Non-Cash-$10$0-$8-$2
Operating Cash Flow$19$18$13$19
Investing Activities
PP&E Inv.-$14-$13-$8-$4
Net Acquisitions$0-$7$1-$1
Inv. Purchases-$1-$0-$6-$0
Inv. Sales/Matur.$8$2$2$2
Other Inv. Act.$24$16-$13-$10
Investing Cash Flow$18-$3-$24-$13
Financing Activities
Debt Repay.$2-$0-$0-$0
Stock Issued$0$0$0$0
Stock Repurch.-$11-$10-$8-$8
Dividends Paid-$7-$7-$7-$7
Other Fin. Act.-$0-$0-$0-$0
Financing Cash Flow-$16-$17-$15-$15
Forex Effect$3$2$5$4
Net Chg. in Cash$23$1-$21-$5
Supplemental Information
Beg. Cash$66$65$86$91
End Cash$90$66$65$86
Free Cash Flow$5$5$5$15